Shareholders Approve 17M New Shares for Equity Plans, Enhance Governance
AKAM has more than doubled off its 52-week low of $69.78 on elevated volume (1.9× avg).
Summary
Akamai Technologies shareholders approved the authorization of 17 million new shares for employee equity compensation plans, representing significant potential dilution, while also enhancing corporate governance by allowing 25% of shareholders to call special meetings.
Key Events · Corporate Governance and Compliance · AKAM
-
Authorization of 17 Million New Shares
Shareholders approved 8 million additional shares for the 2013 Stock Incentive Plan and 9 million shares for the new 2026 Employee Stock Purchase Plan. If all authorized shares were issued, dilution would be approximately 11.7%.
-
Enhanced Shareholder Rights
Stockholders approved an amendment to the Certificate of Incorporation, allowing holders of at least 25% of outstanding shares to call a special meeting.
-
Annual Meeting Results
Routine election of directors, approval of executive compensation, and ratification of the independent auditor were also confirmed.
Analysis · AKAM · Trade & Services
Akamai Technologies' shareholders approved the authorization of 17 million new shares for its equity compensation plans (8 million for the incentive plan and 9 million for the employee stock purchase plan). This represents a substantial potential dilution of approximately 11.7% if all authorized shares were issued, which could weigh on existing shareholder value. Concurrently, shareholders approved a significant corporate governance enhancement, granting stockholders owning at least 25% of outstanding shares the right to call a special meeting. This increases shareholder influence and is generally viewed positively. The company's stock is currently trading near its 52-week high.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AKAM was trading at $161.74 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $23.4B. The 52-week trading range was $69.78 to $165.45. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.